Home » Topics » Regulatory » Patents

Patents
RSS

Novel progestins/antiprogestins disclosed by Ortho

June 30, 1997

ET antagonists disclosed by Roussel Uclaf

June 30, 1997

Inhibitors of MHC class II binding from Merck & Co.

June 30, 1997

Ajinomoto prepares peptides for treating or preventing human gastric cancer

June 30, 1997

Kyowa Hakko discloses new calcitonin derivatives

June 27, 1997

Novel semisynthetic macrolides from Abbott

June 27, 1997

Hoechst reveals new Na+/H+ exchange inhibitors

June 27, 1997

MS&D reports another series of potent and selective 5-HT1D agonists

June 27, 1997

Univ. of Pittsburgh claims inhibitors of farnesyltransferase/geranylgeranyltransferase

June 27, 1997

Thrombin inhibitors from Akzo Nobel

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.